Icon plc

ICON plc
TypePublic
Nasdaq: ICLR
Industry
Founded1990; 36 years ago (1990) in Dublin, Ireland
Founders
  • John Climax
  • Ronan Lambe
Headquarters
Dublin
,
Ireland
Key people
  • Barry Balfe (CEO)
  • Nigel Clerkin (CFO)
ProductsServices for pharmaceutical, biotech and medical device industries
RevenueIncrease US$8.28 billion (2024)
Increase US$705.05 million (2024)
Total assetsDecrease US$16.88 billion (2024)
Number of employees
40,100 (2025)
Websitewww.iconplc.com

Icon plc (stylized as "ICON") is an Irish-headquartered multinational clinical research organisation (CRO). Icon conducts clinical trials on behalf of pharmaceutical and biotechnology companies and provides services related to drug development and guiding clinical trial progress.

As of December 2025 Icon had approximately 40,100 employees in 55 countries.

Operations

Icon provides outsourced drug development, clinical research, and consulting services for pharmaceutical, biotechnology, medical device, and government organizations. The company supports therapies throughout the development lifecycle, from early-stage research and clinical trial design through Phase I–IV clinical trials and commercialization. Its services include clinical trial management, laboratory and imaging services, patient recruitment, data analysis, and regulatory and market access consulting across a range of therapeutic areas.

History

Icon was founded in Ireland, by John Climax and Ronan Lambe in 1990. Since January 2010, Climax has held a position on the board of directors. Lambe retired from the board of directors in 2018.

Between 1991 and 1996, Icon opened offices in the United Kingdom, United States, Germany, and Japan. Two years later, Icon shares began trading on Nasdaq, providing the company with additional capital to support international expansion and acquisitions.

In 2006, Icon acquired Ovation Research Group, expanding its capabilities in health outcomes research and health economics. In 2014, Icon expanded its capabilities in adaptive clinical trial design and execution with the acquisition of Aptiv Solutions.

In 2021, Icon completed its US$12 billion acquisition of PRA Health Sciences. The transaction expanded the company's global clinical research operations and created one of the largest contract research organizations.

On September 4, 2025, Icon announced that Steve Cutler would be stepping down from his position as CEO. Barry Balfe, the company's Chief Operating Officer, was promoted to Chief Executive Officer.

Acquisitions

Finances

YearRevenue
(in thousands USD)		Net Income
(in thousands USD)		Total Assets
(in thousands USD)		Employees
(k)
20202,797,288332,9643,435,60615,730
20215,480,826153,18517,387,09038,330
20227,741,386505,30417,185,27841,100
20238,120,176612,33516,989,86341,100
20248,281,676705,05116,877,67841,900
2025 8,251,340 230,363 16,088,220 40,100

Recognition

In 2018, Icon won PharmaTimes Clinical Researcher of the Year. In 2021, Icon was awarded PharmaTimes Clinical Research Company of the Year, and in 2022, won Best Contract Research Organisation (FSP) at the Scrip Awards.

In 2025 Icon was recognized in Forbes World's Top Companies for Women, and in TIME World's Best Companies list. In 2026, the company was recognized by TIME's World's Best Companies in Sustainable Growth for the second consecutive year.

See also

References

  1. ↑ "ICON to Acquire PRA Health Sciences, Creating a World Leader in Healthcare Intelligence and Clinical Research". www.businesswire.com. 2021-02-24. Retrieved 2021-07-01.
  2. ↑ "Facts and Figures". ICON plc. Retrieved 21 April 2025.
  3. ↑ Langan, Sheila (2013-12-05). "ICON of Ireland". Irish America. Retrieved 2026-08-19.
  4. 1 2 Or, Amy (2014-03-31). "Halifax, SV Life Sciences, Comvest Sells Aptiv Solutions to ICON - WSJ". Wall Street Journal. ISSN 0099-9660. Retrieved 2026-07-27.
  5. ↑ "Icon founders poised to make $45m in share placing". Irish Times. 24 July 2003. Retrieved 8 December 2019.
  6. ↑ "Board of Directors". Red Robin Gourmet Burgers, Inc. 2023. Retrieved 2023-11-01.
  7. ↑ Langan, Sheila (1 October 2014). "ICON of Ireland". Irish America. Retrieved 8 December 2019.
  8. ↑ "ICON plc : ICON Announces the Commencement of Direct Trading on NASDAQ". Market Screener. 5 February 2013. Retrieved 8 December 2019.
  9. ↑ Wright, Tim (2006-06-19). "Icon Gets Ovation". Contract Pharma. Retrieved 2026-07-21.
  10. ↑ Hopkins, Jared S. (2021-02-24). "Icon to Buy Clinical-Trial Rival PRA in $12 Billion Deal". Wall Street Journal. ISSN 0099-9660. Retrieved 2026-08-07.
  11. ↑ "BRIEF-ICON says Steve Cutler to be named CEO". Reuters. 20 October 2016. Retrieved 8 December 2019.
  12. ↑ "ICON Announces CEO Transition". Business Wire. Business Wire. 4 September 2025. Retrieved 4 September 2025.
  13. ↑ "YRCR was acquired by Icon on February 3, 2000". Mergr. Retrieved 8 December 2019.
  14. ↑ Barrington, Kathleen (10 June 2000). "Icon buys UCT for $2m cash plus $18m deferred payments". Independent. Retrieved 8 December 2019.
  15. ↑ McGrath, Brendan (1 February 2000). "Icon buys US data group in first public acquisition". The Irish Times. Retrieved 8 December 2019.
  16. ↑ "Form 20-F". Securities and Exchange Commission. United States Government. Retrieved 8 December 2019.
  17. ↑ "Form 20-F". Securities and Exchange Commission. United States Government. Retrieved 8 December 2019.
  18. ↑ "ICON Acquires GloboMax". Mergr. Retrieved 8 December 2019.
  19. ↑ "Beacon Bioscience Acquired by ICON July 1, 2004". Crosstree Capital. Retrieved 8 December 2019.
  20. ↑ "ICON Acquires Ovation Research Group". Mergr. Retrieved 8 December 2019.
  21. ↑ Mansell, Peter (16 July 2007). "ICON acquires clinical research staffer DOCS International". Pharma Times. Retrieved 8 December 2019.
  22. ↑ "ICON Acquires Healthcare Discoveries". Contract Pharma. 12 February 2008. Retrieved 8 December 2019.
  23. ↑ MacDonald, Gareth (22 October 2009). "Icon boosts bioanalytical presence through Prevalere buy". Outsourcing Pharma. Retrieved 8 December 2019.
  24. ↑ "ICON Acquires Veeda Laboratories Ltd". Biospace. 8 December 2008. Retrieved 8 December 2019.
  25. ↑ Rhea, Shawn (24 May 2010). "Icon acquires Timaq Medical Imaging". Modern Healthcare. Retrieved 10 December 2019.
  26. ↑ Mansell, Peter (18 January 2011). "ICON broadens late-phase expertise with Oxford Outcomes acquisition". PharmaTimes. Retrieved 10 December 2019.
  27. ↑ Lynch, Suzanne (15 July 2011). "Pharmaceutical firm Icon buys Firecrest Clinical for undisclosed sum". The Irish Times. Retrieved 10 December 2019.
  28. ↑ "ICON-PLC Acquires PriceSpective". Biospace. 28 February 2012. Retrieved 10 December 2019.
  29. ↑ "ICON Acquires BeijingWits Medical Consulting Ltd". BioSpace. 12 December 2011. Retrieved 10 December 2019.
  30. ↑ "DOCS Acquires ClinForce and Assent Consulting". DOCS Global. DOCS. Archived from the original on 11 December 2019. Retrieved 10 December 2019.
  31. ↑ Mansell, Peter (5 February 2013). "Icon to acquire Cross Country's Clinical Trial Services Division". PharmaTimes. Retrieved 10 December 2019.
  32. ↑ Mansell, Peter (1 April 2014). "ICON to acquire Aptiv Solutions for US$143.5 million". PharmaTimes. Retrieved 10 December 2019.
  33. ↑ "ICON Completes Acquisition Of MediMedia Pharma Solutions". BioSpace. 2 March 2015. Retrieved 10 December 2019.
  34. ↑ "ICON Acquires PMG Research". Contract Pharma. 7 December 2015. Retrieved 10 December 2019.
  35. ↑ "ICON Completes the Acquisition of Clinical Research Management, Inc". BusinessWire. 19 September 2016. Retrieved 10 December 2019.
  36. ↑ "ICON Acquires Mapi Group". Health Economics. Archived from the original on 11 December 2019. Retrieved 10 December 2019.
  37. ↑ "Symphony Clinical Research Acquired by ICON". Symphony Clinical Research. Retrieved 10 December 2019.
  38. ↑ "ICON's Acquisition of MeDiNova Research". Bloomberg. 23 May 2019. Retrieved 10 December 2019.
  39. ↑ Pennic, Fred (21 February 2019). "ICON Acquires Precision Medicine for Oncology Company MolecularMD". HIT Consultant. Retrieved 10 December 2019.
  40. ↑ "ICON Acquires MedPass International". Bloomberg. Retrieved 19 February 2020.
  41. ↑ "ICON to Acquire PRA Health Sciences, Creating a World Leader in Healthcare Intelligence and Clinical Research". www.businesswire.com. 2021-02-24. Retrieved 2021-07-01.
  42. ↑ Parsons, Lucy (2021-02-26). "ICON to acquire PRA Health Sciences in $12bn deal". PharmaTimes. Retrieved 2021-10-19.
  43. ↑ "ICON plc Annual Form 20-F Report 2020". U.S. Securities and Exchange Commission. 24 February 2021. Retrieved 21 April 2025.
  44. ↑ "ICON plc Annual Form 20-F Report 2021". U.S. Securities and Exchange Commission. 1 March 2022. Retrieved 21 April 2025.
  45. ↑ "ICON plc Annual Form 20-F Report 2022". U.S. Securities and Exchange Commission. 24 February 2023. Retrieved 21 April 2025.
  46. ↑ "ICON plc Annual Form 20-F Report 2023". U.S. Securities and Exchange Commission. 23 February 2024. Retrieved 21 April 2025.
  47. ↑ "ICON plc Annual Form 20-F Report 2024". U.S. Securities and Exchange Commission. 21 February 2025. Retrieved 21 April 2025.
  48. ↑ "XBRL Viewer". www.sec.gov. Retrieved 2026-07-10.
  49. ↑ "Winner 2018". Pharma Times. December 2018. Archived from the original on 11 December 2019. Retrieved 8 December 2019.
  50. ↑ "Clinical Researcher of the Year - The Americas 2021 winners announced". Pharma Times. October 2021. Retrieved 29 October 2021.
  51. ↑ "Scrip Awards 2022 Winners have been Announced". Pharma Intelligence UK Limited. November 2022. Retrieved 30 November 2022.
  52. ↑ Peachman, Rachel Rabkin. "Forbes World's Top Companies For Women 2025 List". Forbes. Retrieved 2026-08-31.
  53. ↑ Hu, Charlotte (2025-09-10). "World's Best Companies of 2025". TIME. Retrieved 2026-08-31.
  54. ↑ "Wold's Best Companies in Sustainable Growth 2025". TIME. 2024-11-27. Retrieved 2026-08-31.